Pharmaceuticals

Animal Model Industry Growth Insights: Revenue Forecast to 2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the animal model market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Animal Model Market by the end of 2030?

The animal model market has experienced robust expansion over recent years. This market is projected to expand from $2.07 billion in 2025 to $2.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. Historically, this growth has been driven by factors such as the increasing incidence of chronic diseases, the rising demand for preclinical research, the growth in pharmaceutical R&D, technological advancements in laboratory equipment, and the expansion of academic research institutions.

The animal model market is projected to experience substantial expansion over the upcoming years, reaching $2.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.3%. This anticipated growth is primarily fueled by factors such as the integration of AI and machine learning into preclinical studies, the proliferation of precision medicine initiatives, the increasing role of CROs and outsourcing, the broadening scope of genetically modified animal models, and a heightened emphasis on translational research. Key developments expected during this period involve the creation of advanced animal models, the utilization of genetically engineered models, the implementation of high-throughput screening in preclinical research, the incorporation of imaging and diagnostic technologies, and the continued expansion of contract research organizations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

What Drivers Are Shaping Future Opportunities In The Animal Model Market?

The increasing investment in pharmaceutical research and development (R&D) is projected to boost the growth of the animal model market. Pharmaceutical R&D involves the discovery, development, and rigorous testing of new therapies, which necessitates comprehensive preclinical studies to assess their safety, effectiveness, and biological mechanisms before proceeding to human trials. The rise in R&D spending stems from a growing need for innovative treatments, the increasing prevalence of complex diseases, and ongoing scientific progress. Animal models are pivotal in this process, offering dependable preclinical platforms that accurately mimic human physiology, allowing for a predictive evaluation of drug performance. For instance, according to a report published in November 2023 by the European Federation of Pharmaceutical Industries and Associations, pharmaceutical industry research and development expenditure rose to 50,000 million in 2023, an increase from 47,010 million in 2022. Therefore, the expanding pharmaceutical R&D expenditure is a significant driver for the growth of the animal model market.

Which Segments Are Gaining Traction In The Animal Model Market?

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Which Trends Are Influencing The Development Of The Animal Model Market?

Leading companies in the animal model market are concentrating on developing innovative products, such as triple-immunodeficient animal models, to improve the accuracy and reliability of preclinical studies, support advanced biomedical research, and facilitate the creation of new therapies for complex human diseases. Triple-immunodeficient animal models are specially engineered animals, typically mice, that lack three critical components of the immune system. These models are exceptionally valuable in biomedical research, particularly for investigating human diseases and developing novel treatments. For instance, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, introduced NCG mouse strains, a triple-immunodeficient mouse model intended for oncology research. NCG mice are triple immunodeficient, meaning they are devoid of functional/mature T, B, and NK cells, and exhibit reduced macrophage and dendritic cell function. These animal models are able to host xenograft cells, tissues, and human immune system components. This mouse model is optimal for research in oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. NCG mice also have the capability to create humanized mice by engrafting PBMCs or CD34+ stem cells, thereby closely mimicking the human immune system.

Who Are The Top-Performing Companies In The Animal Model Market In Recent Years?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Which Region Currently Holds The Largest Share Of The Animal Model Market?

North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Animal Model Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

Browse Through More Reports Similar to the Global Animal Model Market 2026, By The Business Research Company

Animal Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Rat Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Anatomical Models Market Report 2026

https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795